According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are โฌ0.45 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | โฌ0.47 B | 0.78% |
2023-12-31 | โฌ0.46 B | -8.8% |
2022-12-31 | โฌ0.51 B | -1.27% |
2021-12-31 | โฌ0.51 B | 90.84% |
2020-12-31 | โฌ0.27 B | 73.92% |
2019-12-31 | โฌ0.15 B | 21.9% |
2018-12-31 | โฌ0.12 B | -13.6% |
2017-12-31 | โฌ0.14 B | 73.93% |
2016-12-31 | โฌ85.41 M | -23.67% |
2015-12-31 | โฌ0.11 B | -0.56% |
2014-12-31 | โฌ0.11 B | 218.06% |
2013-12-31 | โฌ35.38 M | -18.51% |
2012-12-31 | โฌ43.42 M | -31.4% |
2011-12-31 | โฌ63.3 M | -23.07% |
2010-12-31 | โฌ82.28 M | -17.09% |
2009-12-31 | โฌ99.24 M | 63.82% |
2008-12-31 | โฌ60.58 M | -38.02% |
2007-12-31 | โฌ97.74 M | 88.32% |
2006-12-31 | โฌ51.9 M | -38.05% |
2005-12-31 | โฌ83.78 M | 250.03% |
2004-12-31 | โฌ23.93 M | 0.13% |
2003-12-31 | โฌ23.9 M | -39.5% |
2002-12-31 | โฌ39.5 M | -40.96% |
2001-12-31 | โฌ66.91 M |